Factor-inhibiting HIF (FIH) promotes lung cancer progression
Factor-inhibiting HIF (FIH) is an asparagine hydroxylase that acts on hypoxia-inducible factors (HIFs) to control cellular adaptation to hypoxia. FIH is expressed in several tumor types, but its impact in tumor progression remains largely unexplored. We observed that FIH was expressed on human lung...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Clinical investigation
2023-10-01
|
| Schriftenreihe: | JCI Insight |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1172/jci.insight.167394 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
